Innate Biologics, LLC is a pioneer in targeting, treating and preventing inflammation through the development of a first of its kind recombinant protein platform which specifically targets intracellular inflammatory signaling pathways.
Phoenixville, PA, USA
Sep 24, 2019
United States Patent and Trademark Office Issues Innate Biologics™ E3 Ligase Effector Protein Patent
Mar 21, 2018
Innate Biologics, LLC Enters Into Collaboration Agreement With The Wistar Institute to Develop Anti-Inflammatory Protein Platform
For More Press Releases